Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05169437
Title Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tempus Labs
Indications

Advanced Solid Tumor

Therapies

Niraparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.